HedgeChatter

  • Home /
  • Tag Archives

VRTX

William Young Joins Vertex Board of Directors

[Business Wire] – Vertex Pharmaceuticals Incorporated today announced that William Young joined its board of directors as an independent director. Mr. Young was elected to the class of directors whose term expires in 2017. moreView todays social media effects on VRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Vertex is hiring next, click here to view […]

May 7, 2014 Bystocknews , Comments Off on William Young Joins Vertex Board of Directors read more

Vertex Down on Wider-than-Expected Loss

moreView todays social media effects on VRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Vertex is hiring next, click here to view […]

May 5, 2014 Bystocknews , Comments Off on Vertex Down on Wider-than-Expected Loss read more

4:04 pm Vertex Pharm: Addition of VX-661 to KALYDECO (ivacaftor) improves lung function in people with CF who are heterozygous for the F508del and G551D mutations in 28-day Phase 2 proof-of-concept study

moreView todays social media effects on VRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Vertex is hiring next, click here to view […]

May 2, 2014 Bystocknews , Comments Off on 4:04 pm Vertex Pharm: Addition of VX-661 to KALYDECO (ivacaftor) improves lung function in people with CF who are heterozygous for the F508del and G551D mutations in 28-day Phase 2 proof-of-concept study read more

Vertex Pharmaceuticals Incorporated Management Discusses Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Jeffrey A. Chodakewitz Thanks, Jeff, and good evening. It’s a pleasure to speak with you all today. I’ll provide an overview of some important progress we’ve made with our 3 CF development programs, specifically, … moreView todays social media effects on VRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Vertex is hiring […]

May 2, 2014 Bystocknews , Comments Off on Vertex Pharmaceuticals Incorporated Management Discusses Q1 2014 Results – Earnings Call Transcript read more